{
  "retracted": false,
  "timestamp": 1563235200000,
  "updates": [
    {
      "timestamp": 1585238096558,
      "identifier": {
        "doi": "10.1073/pnas.1909768116"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1073/pnas.1819992116"
  },
  "publisher": "Proceedings of the National Academy of Sciences",
  "title": "Correction for Borot et al., Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies"
}
